Literature DB >> 6086188

The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.

C A Kraaijeveld, M Schilham, J Jansen, B Benaissa-Trouw, M Harmsen, A J van Houte, H Snippe.   

Abstract

The primary neutralizing antibody response to encephalomyocarditis (EMC) virus and Semliki Forest virus (SFV) is enhanced by addition of either negatively or positively charged liposomes. The purified u.v. light inactivated viruses were merely mixed with liposomes and injected intraperitoneally (i.p.) into mice. In contrast, neutral liposomes were unable to enhance the primary response to these viruses. Furthermore primary immunization with inactivated SFV mixed with either neutral, positively or negatively charged liposomes was associated with an enhancement of the secondary humoral response after i.p. booster injection of mice with inactivated virus alone. But neutral liposomes seemed to be less effective in this respect than either positively or negatively charged liposomes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086188      PMCID: PMC1535983     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Structure of the mengo virion. VI. Spatial relationships of the capsid polypeptides as determined by chemical cross-linking analyses.

Authors:  J S Hordern; J D Leonard; D G Scraba
Journal:  Virology       Date:  1979-08       Impact factor: 3.616

2.  Hepatitis-B-surface-antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen [proceedings].

Authors:  E K Manesis; C H Cameron; G Gregoriadis
Journal:  Biochem Soc Trans       Date:  1979-08       Impact factor: 5.407

3.  Diffusion of univalent ions across the lamellae of swollen phospholipids.

Authors:  A D Bangham; M M Standish; J C Watkins
Journal:  J Mol Biol       Date:  1965-08       Impact factor: 5.469

4.  Liposomes in immunology: evidence that their adjuvant effect results from surface exposition of the antigens.

Authors:  N van Rooijen; R van Nieuwmegen
Journal:  Cell Immunol       Date:  1980-02       Impact factor: 4.868

Review 5.  Picornaviral structure and assembly.

Authors:  J R Putnak; B A Phillips
Journal:  Microbiol Rev       Date:  1981-06

6.  Delayed-type hypersensitivity against Semliki Forest virus in mice.

Authors:  C A Kraaijeveld; M Harmsen; B Khader Boutahar-Trouw
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  The effect of enzymes on structural and biological properties of Semliki forest virus.

Authors:  S I Kennedy
Journal:  J Gen Virol       Date:  1974-05       Impact factor: 3.891

8.  Investigations into yellow fever virus and other arboviruses in the northern regions of Kenya.

Authors:  B E Henderson; D Metselaar; G B Kirya; G L Timms
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virus.

Authors:  C A Kraaijeveld; G la Rivière; B J Benaissa-Trouw; J Jansen; T Harmsen; H Snippe
Journal:  Antiviral Res       Date:  1983-09       Impact factor: 5.970

10.  Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity.

Authors:  A J van Houte; H Snippe; M G Schmitz; J M Willers
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

View more
  5 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes.

Authors:  W Jiskoot; T Teerlink; M M Van Hoof; K Bartels; V Kanhai; D J Crommelin; E C Beuvery
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 3.  Platform technologies for modern vaccine manufacturing.

Authors:  Hayley K Charlton Hume; Linda H L Lua
Journal:  Vaccine       Date:  2017-03-25       Impact factor: 3.641

4.  Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.

Authors:  Karoliina P M Autio; Janne J Ruotsalainen; Marjukka O Anttila; Minna Niittykoski; Matti Waris; Akseli Hemminki; Markus J V Vähä-Koskela; Ari E Hinkkanen
Journal:  BMC Vet Res       Date:  2015-07-28       Impact factor: 2.741

Review 5.  Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.

Authors:  Signe Tandrup Schmidt; Camilla Foged; Karen Smith Korsholm; Thomas Rades; Dennis Christensen
Journal:  Pharmaceutics       Date:  2016-03-10       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.